Doctor profile · Federal record
Dr. Casey Jankord, PA-C
Physician Assistant · Manhattan, KS
- NPI 1457752537
- Accepts Medicare
- MIPS 90.7 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4201 Anderson Ave Ste F
Manhattan, KS 665037603
(785) 539-4645
fax (785) 539-1655 - Additional location
-
617 Liberty St
Clay Center, KS 674321564 - Mailing address
-
9300 E 29Th St N Ste 310
Wichita, KS 672262160
Credentials & registration
- NPI registered
- September 2014 — 12 yrs on file
- Profile last updated
- October 2, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Kansas #15-01721
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457752537. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,816
Distinct HCPCS
10
Medicare allowed
$113,410
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,195 | 197 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 572 | 387 | $72 | |
17000 |
Destruction of precancer skin growth, 1 growth | 348 | 275 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 223 | 193 | $79 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 139 | 119 | $45 | |
11103 |
Biopsy of related skin growth, each additional growth | 107 | 64 | $40 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 101 | 101 | $89 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 57 | 45 | $134 | |
11104 |
Punch biopsy, first skin growth | 21 | 20 | $99 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 21 | 21 | $58 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 151. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$3,068
Transactions
147
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 36 | $665.11 | |
| E.R. Squibb & Sons, L.L.C. | 22 | $534.44 | |
| Janssen Biotech, Inc. | 13 | $369.82 | |
| Incyte Corporation | 9 | $237.39 | |
| Dermavant Sciences, Inc. | 19 | $199.38 | |
| Novartis Pharmaceuticals Corporation | 13 | $184.14 | |
| Regeneron Healthcare Solutions, Inc. | 8 | $158.98 | |
| Amgen Inc. | 8 | $154.14 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $141.87 | |
| Lilly USA, LLC | 3 | $70.99 | |
| ConvaTec Inc. | 2 | $64.85 | |
| LEO Pharma Inc. | 3 | $52.78 | |
| Organon Llc | 2 | $40.81 | |
| Kerecis Limited | 2 | $40.75 | |
| Mallinckrodt Hospital Products Inc. | 1 | $38.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
175
Patients
104
Total drug cost
$4,245
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 61 | 53 | $1,302 |
| Triamcinolone Acetonide | Generic | 29 | 28 | $163 |
| Doxycycline Hyclate | Generic | 22 | 0 | $521 |
| Ketoconazole | Generic | 17 | 11 | $309 |
| Betamethasone Dipropionate | Generic | 16 | 12 | $895 |
| Prednisone | Generic | 16 | 0 | $120 |
| Clobetasol Propionate | Generic | 14 | 0 | $935 |
Frequently asked questions
What is Dr. Casey Jankord's medical specialty?
Dr. Casey Jankord practices Physician Assistant in Manhattan, KS.
Where does Dr. Casey Jankord practice?
Dr. Casey Jankord practices at 4201 Anderson Ave Ste F, Manhattan, KS 665037603. Office phone: 7855394645.
What is Dr. Casey Jankord's NPI?
Dr. Casey Jankord's National Provider Identifier (NPI) is 1457752537, issued by NPPES.
Does Dr. Casey Jankord accept Medicare assignment?
Yes. Dr. Casey Jankord accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Casey Jankord commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.